nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—ADRB1—dilated cardiomyopathy	0.397	0.543	CbGaD
Asenapine—ADRB2—dilated cardiomyopathy	0.334	0.457	CbGaD
Asenapine—HTR2B—cardial valve—dilated cardiomyopathy	0.0149	0.316	CbGeAlD
Asenapine—Depressive symptom—Lisinopril—dilated cardiomyopathy	0.00523	0.0593	CcSEcCtD
Asenapine—HTR7—pulmonary artery—dilated cardiomyopathy	0.00518	0.11	CbGeAlD
Asenapine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.00503	0.107	CbGeAlD
Asenapine—Blood cholesterol increased—Furosemide—dilated cardiomyopathy	0.00378	0.0429	CcSEcCtD
Asenapine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00323	0.0683	CbGeAlD
Asenapine—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00319	0.0361	CcSEcCtD
Asenapine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00314	0.0665	CbGeAlD
Asenapine—Ulcer—Spironolactone—dilated cardiomyopathy	0.00296	0.0335	CcSEcCtD
Asenapine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0025	0.0284	CcSEcCtD
Asenapine—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00232	0.0263	CcSEcCtD
Asenapine—DRD4—heart—dilated cardiomyopathy	0.00225	0.0476	CbGeAlD
Asenapine—Blister—Furosemide—dilated cardiomyopathy	0.00211	0.0239	CcSEcCtD
Asenapine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00146	0.0166	CcSEcCtD
Asenapine—HRH2—heart—dilated cardiomyopathy	0.00139	0.0294	CbGeAlD
Asenapine—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00131	0.0278	CbGeAlD
Asenapine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00127	0.0144	CcSEcCtD
Asenapine—Swelling—Furosemide—dilated cardiomyopathy	0.00125	0.0142	CcSEcCtD
Asenapine—ADRB1—myocardium—dilated cardiomyopathy	0.00123	0.0261	CbGeAlD
Asenapine—HRH2—cardiac atrium—dilated cardiomyopathy	0.00119	0.0252	CbGeAlD
Asenapine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00118	0.0133	CcSEcCtD
Asenapine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00116	0.0131	CcSEcCtD
Asenapine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00114	0.013	CcSEcCtD
Asenapine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00114	0.0129	CcSEcCtD
Asenapine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00111	0.0126	CcSEcCtD
Asenapine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00111	0.0126	CcSEcCtD
Asenapine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00111	0.0126	CcSEcCtD
Asenapine—Malaise—Spironolactone—dilated cardiomyopathy	0.0011	0.0125	CcSEcCtD
Asenapine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0011	0.0124	CcSEcCtD
Asenapine—Irritability—Furosemide—dilated cardiomyopathy	0.00106	0.012	CcSEcCtD
Asenapine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00101	0.0114	CcSEcCtD
Asenapine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000999	0.0113	CcSEcCtD
Asenapine—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.000989	0.0209	CbGeAlD
Asenapine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000978	0.0111	CcSEcCtD
Asenapine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000953	0.0108	CcSEcCtD
Asenapine—ADRA2C—myocardium—dilated cardiomyopathy	0.00093	0.0197	CbGeAlD
Asenapine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000888	0.0101	CcSEcCtD
Asenapine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000862	0.00977	CcSEcCtD
Asenapine—ADRB1—heart—dilated cardiomyopathy	0.000862	0.0183	CbGeAlD
Asenapine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000862	0.00977	CcSEcCtD
Asenapine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000857	0.00971	CcSEcCtD
Asenapine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000833	0.00944	CcSEcCtD
Asenapine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000829	0.0094	CcSEcCtD
Asenapine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000829	0.0094	CcSEcCtD
Asenapine—HTR2B—heart—dilated cardiomyopathy	0.000825	0.0175	CbGeAlD
Asenapine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000806	0.00913	CcSEcCtD
Asenapine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000795	0.00901	CcSEcCtD
Asenapine—Irritability—Lisinopril—dilated cardiomyopathy	0.000792	0.00897	CcSEcCtD
Asenapine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000757	0.00859	CcSEcCtD
Asenapine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000749	0.0085	CcSEcCtD
Asenapine—ADRB1—cardiac atrium—dilated cardiomyopathy	0.000737	0.0156	CbGeAlD
Asenapine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000736	0.00834	CcSEcCtD
Asenapine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000715	0.0081	CcSEcCtD
Asenapine—HTR7—heart—dilated cardiomyopathy	0.000707	0.015	CbGeAlD
Asenapine—Angiopathy—Furosemide—dilated cardiomyopathy	0.000694	0.00787	CcSEcCtD
Asenapine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000691	0.00783	CcSEcCtD
Asenapine—ADRA1A—heart—dilated cardiomyopathy	0.000682	0.0144	CbGeAlD
Asenapine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00067	0.0076	CcSEcCtD
Asenapine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000666	0.00755	CcSEcCtD
Asenapine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00066	0.00749	CcSEcCtD
Asenapine—Weight increased—Lisinopril—dilated cardiomyopathy	0.000652	0.0074	CcSEcCtD
Asenapine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000652	0.00739	CcSEcCtD
Asenapine—ADRA2C—heart—dilated cardiomyopathy	0.000649	0.0138	CbGeAlD
Asenapine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000647	0.00733	CcSEcCtD
Asenapine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00064	0.00726	CcSEcCtD
Asenapine—Depression—Lisinopril—dilated cardiomyopathy	0.000637	0.00722	CcSEcCtD
Asenapine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000635	0.0072	CcSEcCtD
Asenapine—Rash—Spironolactone—dilated cardiomyopathy	0.00063	0.00714	CcSEcCtD
Asenapine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000629	0.00713	CcSEcCtD
Asenapine—Headache—Spironolactone—dilated cardiomyopathy	0.000626	0.00709	CcSEcCtD
Asenapine—Anaemia—Furosemide—dilated cardiomyopathy	0.000615	0.00697	CcSEcCtD
Asenapine—Agitation—Furosemide—dilated cardiomyopathy	0.000612	0.00693	CcSEcCtD
Asenapine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000604	0.00685	CcSEcCtD
Asenapine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000596	0.00676	CcSEcCtD
Asenapine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000596	0.00675	CcSEcCtD
Asenapine—Nausea—Spironolactone—dilated cardiomyopathy	0.000593	0.00672	CcSEcCtD
Asenapine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000565	0.00641	CcSEcCtD
Asenapine—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000555	0.0118	CbGeAlD
Asenapine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000554	0.00628	CcSEcCtD
Asenapine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000543	0.00616	CcSEcCtD
Asenapine—Shock—Furosemide—dilated cardiomyopathy	0.000534	0.00606	CcSEcCtD
Asenapine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000533	0.00604	CcSEcCtD
Asenapine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000532	0.00603	CcSEcCtD
Asenapine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000521	0.0059	CcSEcCtD
Asenapine—ADRA2A—heart—dilated cardiomyopathy	0.000518	0.011	CbGeAlD
Asenapine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000517	0.00586	CcSEcCtD
Asenapine—Hypotension—Furosemide—dilated cardiomyopathy	0.000508	0.00575	CcSEcCtD
Asenapine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000503	0.0057	CcSEcCtD
Asenapine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000499	0.00566	CcSEcCtD
Asenapine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000489	0.00554	CcSEcCtD
Asenapine—Somnolence—Furosemide—dilated cardiomyopathy	0.000483	0.00548	CcSEcCtD
Asenapine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00048	0.00544	CcSEcCtD
Asenapine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000469	0.00532	CcSEcCtD
Asenapine—Fatigue—Furosemide—dilated cardiomyopathy	0.000468	0.00531	CcSEcCtD
Asenapine—Tremor—Lisinopril—dilated cardiomyopathy	0.000468	0.0053	CcSEcCtD
Asenapine—Constipation—Furosemide—dilated cardiomyopathy	0.000465	0.00527	CcSEcCtD
Asenapine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000462	0.00523	CcSEcCtD
Asenapine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000456	0.00517	CcSEcCtD
Asenapine—Malaise—Lisinopril—dilated cardiomyopathy	0.00045	0.00511	CcSEcCtD
Asenapine—Syncope—Lisinopril—dilated cardiomyopathy	0.000448	0.00508	CcSEcCtD
Asenapine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000447	0.00507	CcSEcCtD
Asenapine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000443	0.00939	CbGeAlD
Asenapine—HTR2A—heart—dilated cardiomyopathy	0.000441	0.00933	CbGeAlD
Asenapine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000439	0.00498	CcSEcCtD
Asenapine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000425	0.00482	CcSEcCtD
Asenapine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000424	0.0048	CcSEcCtD
Asenapine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000416	0.00471	CcSEcCtD
Asenapine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000408	0.00462	CcSEcCtD
Asenapine—Shock—Lisinopril—dilated cardiomyopathy	0.000401	0.00455	CcSEcCtD
Asenapine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0004	0.00454	CcSEcCtD
Asenapine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000399	0.00452	CcSEcCtD
Asenapine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000398	0.00451	CcSEcCtD
Asenapine—Asthenia—Furosemide—dilated cardiomyopathy	0.00039	0.00442	CcSEcCtD
Asenapine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000381	0.00432	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000371	0.00421	CcSEcCtD
Asenapine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000369	0.00418	CcSEcCtD
Asenapine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000363	0.00412	CcSEcCtD
Asenapine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000362	0.00411	CcSEcCtD
Asenapine—Dizziness—Furosemide—dilated cardiomyopathy	0.000359	0.00407	CcSEcCtD
Asenapine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000359	0.00407	CcSEcCtD
Asenapine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000352	0.00399	CcSEcCtD
Asenapine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000351	0.00398	CcSEcCtD
Asenapine—Constipation—Lisinopril—dilated cardiomyopathy	0.000349	0.00395	CcSEcCtD
Asenapine—Vomiting—Furosemide—dilated cardiomyopathy	0.000345	0.00392	CcSEcCtD
Asenapine—Rash—Furosemide—dilated cardiomyopathy	0.000343	0.00388	CcSEcCtD
Asenapine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000342	0.00388	CcSEcCtD
Asenapine—Headache—Furosemide—dilated cardiomyopathy	0.00034	0.00386	CcSEcCtD
Asenapine—Nausea—Furosemide—dilated cardiomyopathy	0.000323	0.00366	CcSEcCtD
Asenapine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0003	0.0034	CcSEcCtD
Asenapine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000292	0.00332	CcSEcCtD
Asenapine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00027	0.00306	CcSEcCtD
Asenapine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000259	0.00294	CcSEcCtD
Asenapine—Rash—Lisinopril—dilated cardiomyopathy	0.000257	0.00291	CcSEcCtD
Asenapine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000257	0.00291	CcSEcCtD
Asenapine—Headache—Lisinopril—dilated cardiomyopathy	0.000255	0.00289	CcSEcCtD
Asenapine—Nausea—Lisinopril—dilated cardiomyopathy	0.000242	0.00274	CcSEcCtD
Asenapine—Loxapine—ADRB1—dilated cardiomyopathy	0.000215	1	CrCbGaD
Asenapine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.75e-05	0.000131	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.75e-05	0.000131	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.75e-05	0.000131	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.74e-05	0.000131	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AGT—dilated cardiomyopathy	1.74e-05	0.000131	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.74e-05	0.000131	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.74e-05	0.00013	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.73e-05	0.00013	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.73e-05	0.00013	CbGpPWpGaD
Asenapine—HTR5A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.72e-05	0.000129	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.72e-05	0.000129	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.71e-05	0.000128	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.7e-05	0.000128	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.7e-05	0.000127	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.69e-05	0.000127	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.69e-05	0.000127	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.69e-05	0.000127	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.68e-05	0.000126	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.67e-05	0.000126	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.67e-05	0.000125	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.66e-05	0.000125	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.66e-05	0.000125	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.66e-05	0.000125	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.64e-05	0.000123	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.64e-05	0.000123	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.64e-05	0.000123	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.64e-05	0.000123	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.63e-05	0.000123	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.63e-05	0.000122	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.62e-05	0.000121	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.62e-05	0.000121	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.62e-05	0.000121	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.61e-05	0.000121	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.6e-05	0.00012	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.6e-05	0.00012	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.59e-05	0.000119	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.59e-05	0.000119	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	1.59e-05	0.000119	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.59e-05	0.000119	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.58e-05	0.000118	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.58e-05	0.000118	CbGpPWpGaD
Asenapine—HTR1E—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.57e-05	0.000118	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.57e-05	0.000118	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.57e-05	0.000118	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.57e-05	0.000118	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.57e-05	0.000118	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.56e-05	0.000117	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.56e-05	0.000117	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.55e-05	0.000116	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.55e-05	0.000116	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.55e-05	0.000116	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.55e-05	0.000116	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.55e-05	0.000116	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.54e-05	0.000115	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.54e-05	0.000115	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.53e-05	0.000115	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.52e-05	0.000114	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.52e-05	0.000114	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.51e-05	0.000113	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.51e-05	0.000113	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.5e-05	0.000113	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.5e-05	0.000113	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.49e-05	0.000112	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.48e-05	0.000111	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.48e-05	0.000111	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.47e-05	0.00011	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.47e-05	0.00011	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.47e-05	0.00011	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.46e-05	0.00011	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.46e-05	0.000109	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.45e-05	0.000109	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.45e-05	0.000108	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.43e-05	0.000107	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.42e-05	0.000107	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.42e-05	0.000106	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.42e-05	0.000106	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.41e-05	0.000106	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.4e-05	0.000105	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.4e-05	0.000105	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	1.4e-05	0.000105	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.4e-05	0.000105	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	1.4e-05	0.000105	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.38e-05	0.000104	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.38e-05	0.000103	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.36e-05	0.000102	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.36e-05	0.000102	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—RAF1—dilated cardiomyopathy	1.36e-05	0.000102	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.35e-05	0.000101	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	1.34e-05	0.0001	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	1.34e-05	0.0001	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.33e-05	0.0001	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	1.33e-05	0.0001	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.33e-05	0.0001	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.33e-05	9.99e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.33e-05	9.99e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.33e-05	9.94e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.33e-05	9.94e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.32e-05	9.86e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.31e-05	9.86e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.31e-05	9.85e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	1.3e-05	9.78e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.3e-05	9.73e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.29e-05	9.7e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.29e-05	9.67e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.28e-05	9.59e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	1.28e-05	9.58e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.28e-05	9.57e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	9.53e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.23e-05	9.25e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.22e-05	9.14e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.21e-05	9.11e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.21e-05	9.1e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.21e-05	9.08e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.21e-05	9.06e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.2e-05	9.02e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.2e-05	9.02e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.2e-05	8.98e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.19e-05	8.91e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.19e-05	8.91e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.19e-05	8.9e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.19e-05	8.9e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.17e-05	8.78e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.17e-05	8.78e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.16e-05	8.71e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.16e-05	8.67e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.15e-05	8.64e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.15e-05	8.64e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	1.15e-05	8.62e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.15e-05	8.62e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.15e-05	8.59e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	1.14e-05	8.58e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.14e-05	8.54e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	1.13e-05	8.51e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.13e-05	8.46e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.12e-05	8.43e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.11e-05	8.31e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.1e-05	8.28e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.08e-05	8.11e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.08e-05	8.07e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.07e-05	8.06e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.07e-05	8.04e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.07e-05	8.01e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.06e-05	7.95e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.06e-05	7.94e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.05e-05	7.86e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.05e-05	7.84e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.03e-05	7.76e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.03e-05	7.75e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.03e-05	7.74e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.03e-05	7.72e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.03e-05	7.72e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.02e-05	7.68e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.02e-05	7.65e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.01e-05	7.58e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.01e-05	7.54e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1e-05	7.52e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1e-05	7.51e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1e-05	7.51e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.89e-06	7.42e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	9.89e-06	7.41e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.87e-06	7.4e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	9.83e-06	7.38e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.82e-06	7.37e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.82e-06	7.37e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.69e-06	7.27e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	9.57e-06	7.17e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—EGFR—dilated cardiomyopathy	9.3e-06	6.98e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	9.29e-06	6.97e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	9.27e-06	6.95e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.26e-06	6.95e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	9.26e-06	6.94e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	9.2e-06	6.9e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.14e-06	6.85e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.13e-06	6.85e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.08e-06	6.81e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.01e-06	6.75e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9e-06	6.75e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.94e-06	6.7e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	8.92e-06	6.69e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	8.86e-06	6.65e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.75e-06	6.56e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	8.68e-06	6.51e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	8.54e-06	6.41e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	8.52e-06	6.39e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	8.46e-06	6.34e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	8.36e-06	6.27e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.33e-06	6.24e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	8.29e-06	6.22e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.25e-06	6.19e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.14e-06	6.11e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.13e-06	6.1e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.98e-06	5.98e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.96e-06	5.97e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.92e-06	5.94e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	7.87e-06	5.9e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	7.77e-06	5.83e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.71e-06	5.78e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.17e-06	5.38e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	7.11e-06	5.33e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.02e-06	5.26e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.99e-06	5.24e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.91e-06	5.18e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.88e-06	5.16e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.87e-06	5.15e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.86e-06	5.15e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	6.83e-06	5.12e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.74e-06	5.05e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.72e-06	5.04e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	6.64e-06	4.98e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	6.36e-06	4.77e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	6.35e-06	4.76e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	6.31e-06	4.73e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.26e-06	4.69e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.18e-06	4.63e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	6.08e-06	4.56e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.05e-06	4.54e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.02e-06	4.52e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.93e-06	4.45e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.91e-06	4.44e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	5.85e-06	4.39e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.8e-06	4.35e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	5.8e-06	4.35e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	5.7e-06	4.27e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.47e-06	4.1e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.4e-06	4.05e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.39e-06	4.04e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.13e-06	3.85e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.92e-06	3.69e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.87e-06	3.66e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.81e-06	3.61e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.7e-06	3.53e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	4.68e-06	3.51e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	4.55e-06	3.41e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.51e-06	3.39e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.4e-06	3.3e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.13e-06	3.1e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.06e-06	3.05e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.06e-06	3.04e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.98e-06	2.98e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.96e-06	2.97e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.7e-06	2.77e-05	CbGpPWpGaD
